Better surveillance is needed to halt spread of artemisinin resistant malariaBMJ 2010; 341 doi: http://dx.doi.org/10.1136/bmj.c6558 (Published 18 November 2010) Cite this as: BMJ 2010;341:c6558
- John Zarocostas
Countries where malaria is endemic need to improve monitoring of the effectiveness of drugs to prevent a “dramatic” rise in the cost of the treating the disease, warns the World Health Organization.
“Without regular monitoring and reporting of antimalarial drug resistance, the disease burden and the economic costs of malaria will rise dramatically,” says the agency in a report of its global review of drug effectiveness and resistance over the past decade.
The call comes after the confirmation in February 2009 of the emergence of resistance of Plasmodium falciparum to artemisinin in the Cambodia-Thailand border region.
Pascal Ringwald, from WHO’s drug resistance and containment unit and lead author of …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial